Cannpal has first mover advantage in the $67bn"hidden gem"animal health market - a podcast by Stockhead

from 2020-08-21T16:02

:: ::

This week Tim chats with Layton Mills, managing director of Cannpal Animal Therapeutics (ASX:CP1).

Further episodes of The Health Kick Podcast with Tim Boreham

Further podcasts by Stockhead

Website of Stockhead